Atlas Trials

A Safety Study of NNZ-2566 in Patients With Rett Syndrome

Clinical trial NCT01703533 · COMPLETED

Trial details

NCT number
NCT01703533
Sponsor
Neuren Pharmaceuticals Limited
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rett Syndrome
Start date
2013-03-01
Primary completion
2014-09-01
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.